MIGRAINE AMONG PATIENTS AND PATIENT’S QUALITY OF LIFE: A CROSS-SECTIONAL STUY
Main Article Content
Keywords
Migraine, Pain-killer, Quality of Life, Saudi
Abstract
negatively affects multiple aspects of life which include family relationships, career/financial achievement, stability and overall health. This study aimed to assess the quality of life of migraine and its determinants among patients in clinics.
Methods: This study was a cross sectional study included a convenient sample of migraine patients (15-60 years), followed in 7 clinics at Riyadh, Saudi Arabia. A valid self-assessment questionnaire was utilized for collecting data. It has three parts; sociodemographic data, migraine history and the Arabic version of Migraine-Specific QOL Questionnaire, version 2.1 (MSQ 2.1) to assess quality of life.
Results: A total of 339 migraine patients participated in the study. Majority of them (87.6%) were females and Saudi nationals (92.9%). Their age ranged between 15 and 60 years, with arithmetic mean (±SD) of 36.31±12.56 years. On a scale ranged between 0 and 100, the mean score (±SD) for the restrictive role, preventive role, emotional function domains and the overall QOL were 70.42±22.89, 73.97±22.27, 77.73±21.32 and 73.0±20.78, respectively. Total migraine specific QOL score was highest among patients with intermediate school education (81.2±14.0), p<0.001, retired patients (81.7±18.2), p=0.001. It was significantly higher among never smokers than daily smokers (77.7±20.7 vs. 57.4±29.9), p=0.024 and among those without history of co-morbid chronic diseases compared to those with such history (76.4±21.3 vs.70.5±20.1), p=0.010. It was also highest among patients diagnoses in the past 1-3 years (79.4±16.3), p<0.001, those with less than 12 attacks/year (85.8±20.0), p<0.001, patients who reported no medication intake during migraine attacks (84.4±18.5), p<0.001, patients who reported current intake of prophylactic medication (76.9±19.3), p<0.001, those who took Propranolol (Inderal) as a prophylactic drug (79.2±6.3), p=0.002 and those with no family history of migraine (76.7±21.2), p<0.001.
Conclusions: Migraine impacts the QOL of affected patients in many aspects. Therefore, assessing QOL by treating physicians is very essential to help them in making more suitable prescribing medications.
References
2. Migraine in later life - The Migraine Trust [Internet]. [cited 2021 Feb 3]. Available from: https://www.migrainetrust.org/living-with-migraine/coping-managing/migraine-in-later-life/
3. Yeh WZ, Blizzard L, Taylor B V. What is the actual prevalence of migraine? Brain Behav [Internet]. 2018/05/02. 2018 Jun;8(6):e00950–e00950. Available from: https://www.ncbi. nlm. nih.gov/pubmed/30106228
4. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Cephalalgia [Internet]. 2013/01/10. 2013 Apr;33(5):289–90. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/ 23307815
5. Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache [Internet]. 2013/06/28. 2013 Sep;53(8):1278–99. Available from: https://www.ncbi. nlm. nih.gov/pubmed/23808666
6. Muayqil T, Al-Jafen BN, Al-Saaran Z, Al-Shammari M, Alkthiry A, Muhammad WS, et al. Migraine and Headache Prevalence and Associated Comorbidities in a Large Saudi Sample. Eur Neurol [Internet]. 2018/03/14. 2018;79(3–4):126–34. Available from: https://www.ncbi .nlm.nih.gov/pubmed/29539610
7. WHO | WHOQOL: Measuring Quality of Life. WHO. 2014;
8. Collaborators GBD 2017 D and II and P. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) [Internet]. 2018/11/08. 2018 Nov 10;392(10159):1789–858. Available from: https:// www. ncbi.nlm.nih.gov/pubmed/30496104
9. Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, et al. Life with migraine: Effects on relationships, career, and finances from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache [Internet]. 2019/08/12. 2019 Sep;59(8):1286–99. Available from: https://www.ncbi. nlm.nih.gov/ pubmed/31407321
10. AlHarbi FG, AlAteeq MA. Quality of life of migraine patients followed in clinics in Riyadh, Saudi Arabia. J Fam Community Med. 2021;27(1):37.
11. Shaik MM, Hassan NB, Tan HL, Gan SH. Quality of life and migraine disability among female migraine patients in a tertiary hospital in Malaysia. Biomed Res Int [Internet]. 2015/01/08. 2015;2015:523717. Available from: https://www.ncbi.nlm.nih. gov/ pubmed/25632394
12. About Riyadh [Internet]. [cited 2021 Feb 4]. Available from: https://ngha.med.sa/English/MedicalCities/Riyadh/ Pages/AboutRiyadhAlMunawwarah.aspx
13. MSQ Version 2.1 - Migraine-Specific Quality-of-Life Questionnaire [Internet]. [cited 2021 Feb 5]. Available from: https://eprovide.mapi-trust.org/instruments/migraine-specific-quality-of-life-questionnaire
14. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache [Internet]. 1998 Apr;38(4):295–302. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9595870
15. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877-897.
16. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache. 2018;58:496-505.
17. Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener H-C, et al. My Migraine Voice survey: A global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain. 2018;19:115. https://doi.org/10.1186/s10194-018-0946-z
18. Buse DC, Powers SW, Gelfand AA, VanderPluym JH, Fanning KM, Reed ML, et al. Adolescent perspectives on the burden of a parent’s migraine: Results from the CaMEO Study. Headache. 2018; 58:512-524. https://doi.org/10.1111/head.13254
19. Seng EK, Mauser ED, Marzouk M, Patel ZS, Rosen N, Buse DC. When mom has migraine: An observational study of the impact of parental migraine on adolescent children. Headache. 2019;59:224-234.
20. Facts and Figures-The Migraine Trust. Available from: https://www.migrainetrust. org/about‑migraine/migraine-what-is-it/Facts-figures/. [Last accessed on 2019 Aug 02].
21. Muayqil T, Al-Jafen BN, Al‑Saaran Z, Al-Shammari M, Alkthiry A, Muhammad WS, et al. Migraine and headache prevalence and associated comorbidities in a large Saudi sample. Eur Neurol 2018;79:126-34.
22. Almalki ZA, Alzhrani MAG, Altowairqi AT, Aljawi YA, Fallatah SA, Assaedi LM, et al. Prevalence of migraine headache in Taif City, Saudi Arabia. J Clin Med Res 2018;10:125-33.
23. Vargas LG. Gender Gap in Migraine: A Feminist Understanding of a Comp licated Health Disparity. Bachelor. Tucson: University of Arizona; 2019. Available from: https://repository.arizonaedu/handle/10150/632869. [Last accessed on 2019 Aug 02].
24. Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin 2009;27:321-34.
25. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. 2006;67:246-51.
26. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003;23:519-27.
27. Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm. 2014;20:22-33.
28. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010;9:285-98.
29. Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine=preventive medications among patients with chronic migraine. Cephalalgia 2015;35:478=88.
30. Desouky DE, Zaid HA, Taha AA. Migraine, tension-type headache, and depression among Saudi female students in Taif University. J Egypt Public Health Assoc 2019; 94:7.
31. Ramage-Morin PL, Gilmour H. Prevalence of migraine in the Canadian household population. Health Rep 2014;25:10-6.
32. Tayel SS. Effect of migraine headache on academic performance and quality of life of female students at King Saud University, Kingdom of Saudi Arabia. Bull Alex Fac Med 2008;44:503-9.
33. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American migraine study II. Headache 2001;41:646-57.
34. Smitherman TA, McDermott MJ, Buchanan EM. Negative impact of episodic migraine on a university population: Quality of life, functional impairment, and comorbid psychiatric symptoms. Headache 2011;51:581-9.
35. Shaik MM, Hassan NB, Tan HL, Gan SH. Quality of life and migraine disability among female migraine patients in a tertiary hospital in Malaysia. BioMed Res Int 2015;2015. doi:10.1155/ 2015/523717.
36. Ibrahim NK, Alotaibi AK, Alhazmi AM, Alshehri RZ, Saimaldaher RN, Murad MA. Prevalence, predictors and triggers of migraine headache among medical students and interns in King Abdulaziz University, Jeddah, Saudi Arabia. Pak J Med Sci 2017;33:270-5.
37. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: Will health politicians now take notice? J Headache Pain 2018;19:17
38. Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, et al. Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study. Mayo Clin Proc 2016. pii: S0025-6196 (16) 00126-9.
39. Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe – Evidence from the Eurolight study. J Headache Pain 2018;19:10
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Rahaf Ahmed Ali Alshihri
General Dentist, Primary health care center Al-Athayba, Najran
Rashed Mohammed Hassan Alalhareth
Pharmacy Technicians, Primary health care center in Al-Arissa, Najran
Mohammed Saeed Ali Alalhareth
Epidemiology technician, Primary health care center Al-Athayba, Najran
Abdullah Saeed Ali Alalhareth
Pharmacy, Maternity and Children's Hospital, Najran
Aqeel Mohamed Aqeel Leslom
Anesthesia, King Khaled Hospital in Najran
Abeer Hassan Alhayani
General nursing spicilist Alfahad Aljanobi PHCC Najran
Mohammed hadi algrad
General Dentist, Primary health care center, Bisha
Duaa Jamil Binothman
General Dentist, Primary health care center, Bisha